These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11113662)

  • 1. Hypercalcaemia of hypoadrenal crisis mistaken for hypercalcaemia of malignancy in a patient with known bone metastases: a case report.
    Stanaway SE; Wilding JP
    Eur J Intern Med; 2000 Dec; 11(6):348-350. PubMed ID: 11113662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia.
    Lee AS; Twigg SM
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():150035. PubMed ID: 26161260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
    Links M; Ho H; Clingan P; Diamond T
    Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
    Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemia secondary to hepatocellular carcinoma.
    Leone N; Debernardi-Venon W; Marzano A; Massari M; Rizzetto M
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):604-6. PubMed ID: 10604102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.
    Shek CC; Natkunam A; Tsang V; Cockram CS; Swaminathan R
    Q J Med; 1990 Dec; 77(284):1277-85. PubMed ID: 2290921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcaemia and hypocalcaemia: finding the balance.
    Body JJ; Niepel D; Tonini G
    Support Care Cancer; 2017 May; 25(5):1639-1649. PubMed ID: 28078478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
    Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcaemia in patients with advanced mammary cancer.
    Galasko CS; Burn JI
    Br Med J; 1971 Sep; 3(5774):573-7. PubMed ID: 5571456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hypoadrenalism presenting with hypercalcaemia.
    Vasikaran SD; Tallis GA; Braund WJ
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):261-4. PubMed ID: 7923833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
    Coleman RE; Fogelman I; Rubens RD
    Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening hypercalcaemia in association with Addisonian crisis.
    Miell J; Wassif W; McGregor A; Butler J; Ross R
    Postgrad Med J; 1991 Aug; 67(790):770-2. PubMed ID: 1754531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcaemia and metastatic bone disease: is there a causal link?
    Ralston S; Fogelman I; Gardner MD; Boyle IT
    Lancet; 1982 Oct; 2(8304):903-5. PubMed ID: 6126753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia.
    Neville-Webbe Hl; Coleman RE
    Palliat Med; 2003 Sep; 17(6):539-53. PubMed ID: 14526888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.